2017年8月24日,湖南昭泰醫(yī)療集團(tuán)完全擁有自主知識(shí)產(chǎn)權(quán)的car-t細(xì)胞治療癌癥技術(shù)的一期臨床數(shù)據(jù)成果,已被全球白血病
a novel generation 1928zt2 car t cells induce remission in e
cd215+ myeloid cells respond to interleukin 15 stimulation a
defined, serumfeeder-free conditions for expansion and drug
incorporation of functional elements enhances the antitumor
Incorporation of functional elements enhances the antitumor capacity of CAR T cells